"Global
Tumour Ablation Market", By Type (Tumour Ablation Systems (Radio Frequency
Ablation, Microwave Ablation, HIFU, Laser Ablation, Cryoablation), Image
Guidance Products, Accessories), By Cancer Type (Liver, Lings, Kidney, Brain,
Bone, Pancreas, Breast, Others), By End-User (Hospitals, Oncology Clinics,
Others), By Geography (North America, South America, Europe, Asia-Pacific, Rest
of the World) – Trends and Forecast to 2024
The global
tumour ablation market has accounted for USD 1.8 billion in 2016, expected to
reach USD 3.5 billion by 2024, growing at a CAGR of 8.2% in the forecast period
2017 to 2024.
Request for Sample Report Visit @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-tumour-ablation-market
The global tumour ablation
market is expected to grow, owing to factors such as rising cancer incidence,
increased focus on treatment of breast cancer, better reimbursement scenarios,
shift towards value based reimbursements and continuous development in ablation
technology. The ablation technology has an upper edge on chemotherapy and other
oncology therapeutics. However ablation technology can only be used to treat
tumours with size less than 3cm, owing to the healthy tissue damage caused by
it. With the advent of guidance mechanisms such as ultrasounds and MRI the
accuracy of the treatment has increased significantly in the past 5 years.
Tumour
Ablation Market Market Segmentation:
The
global tumour ablation market is segmented based on product types, cancer
types, end-user and geography.
The
global tumour ablation market is segmented into 3 type’s
ablation systems, image guidance products and accessories. The ablation systems
dominates the market and is further segmented based on product type into
microwave ablation (coretherm thermotherapy devices and prolieve thermotherapy
devices), radiofrequency ablation (RFA) ((temperature controlled devices, fluid
cooled, catheter manipulation systems), high intensity focused ultrasound
(HIFU), laser ablation and cryoablation.
On
the basis of cancer types treated using ablation devices the market is
segmented into liver, lings, kidney, brain, bone, pancreas, breast and, other
cancer types.
Based
on end-user the global tumour ablation market is segmented into hospitals,
oncology clinics and others.
Inquiry
for TOC Visit @ http://databridgemarketresearch.com/toc/?dbmr=global-tumour-ablation-market
Tumour Ablation Market Geographical
Segmentation
Based on geography the
global tumour ablation market is segmented into 5 geographical regions, North
America, Europe, Asia-Pacific, South America and rest of the world. The
geographical regions are further segmented into 24 major countries such as
U.S., Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium,
Turkey, Japan, China, Singapore, Brazil, India, Russia, South Africa and many
others. In 2016, Europe is expected to dominate the market with 36.7% market
share, owing to the large incidence of cancer patients in this region coupled
with good reimbursements.
Tumour Ablation Market Competitive
Landscape:
The tumor ablation market’s
major players have used various strategies such as new product launches,
expansions, agreements, joint ventures, partnerships, acquisitions, and others
to increase their footprints in this market. Some examples of recent
strategies/developments are: On January, 2016 Medtronic acquired OsteoCool RF
Ablation System from Baylis Medical and received its FDA approval, December,
2015 DFINE, Inc. launched Long SpineStar ablation system, January 2015,
Medtronic acquired Covidien to strengthen its leadership in medical devices
industry among others. The report includes market shares of tumor ablation
market for global, Europe, North America, Asia Pacific and Rest of the World.
In 2015, Medtronic has
dominated the global tumor ablation market. Some of the other key players
operating in this market are Galil Medical, Inc., Perseon Corporation, NeuWave
Medical, Inc., Koninklijke Philips N.V., INTIO Inc., Mermaid Medical A/S,
SonaCare Medical, LLC, DFINE, Inc., Misonix, Inc., BVM Medical Limited,
AngioDynamics, Inc., COMSOL Inc., Boston Scientific Corporation, EDAP TMS S.A.
and, HealthTronics, Inc. among other companies.
Read more news about this Report Visit
@ http://databridgemarketresearch.com/reports/global-tumour-ablation-market/
Related
Report
Global
Infection Control Market – Trends and Forecast to 2024
Global Infection
Control Market, By Type (Disinfection (Medical Nonwovens, Disinfectants,
Disinfectors (Washer, Flusher, U.V. Rays), Disinfectant Wipes, Endoscope
Reprocessors), Sterilization (Products (Heat, Low Temperature, Radiation,
Filtration), Services)), By Application, By End-User (Hospitals, Medical Device
Manufacturers, Pharmaceutical Manufacturers, Food and Beverage Industry,
Laboratory), By Geography (North America, Europe, Asia-Pacific, South America,
Middle East and Africa) – Trends and Forecast to 2024
About Data Bridge Market
Research:
Data Bridge
Market Research set forth itself as an unconventional and neoteric
Market research and consulting firm with unparalleled level of resilience and
integrated approaches. We are determined to unearth the best market
opportunities and foster efficient information for your business to thrive in
the market. Data Bridge endeavors to provide appropriate solutions to the
complex business challenges and initiates an effortless decision-making
process.
Contact:
Vishal
Dixit
Data
Bridge Market Research
Tel:
+1-888-387-2818
